title: Harmonization of commercial ELISA methods for the measurement of prothrombin fragment 1.2: is it feasible?
authors.forename: A
authors.initials: A
authors.lastname: D'Angelo
authors.forename: P
authors.initials: P
authors.lastname: Della Valle
authors.forename: G
authors.initials: G
authors.lastname: Calori
authors.forename: L
authors.initials: L
authors.lastname: Galli
authors.forename: S
authors.initials: S
authors.lastname: Vigano D'Angelo
mesh_terms: D000925:Anticoagulants / Q000097:blood / Q000494:pharmacology; D002138:Calibration; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay / Q000592:standards*; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D010446:Peptide Fragments / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*; D011517:Prothrombin Time; D011933:Reagent Kits, Diagnostic / Q000592:standards*
chemical_list: D000925:Anticoagulants; D002951:Citrates; D010446:Peptide Fragments; D011933:Reagent Kits, Diagnostic; C045879:prothrombin fragment 1.2; D019343:Citric Acid; D011516:Prothrombin; D006493:Heparin